Carbonnel F, Colombel JF, Filippi J, Katsanos KH, Peyrin-Biroulet L, Allez M, Nachury M, Novacek G, Danese S, Abitbol V, Bossa F, Moreau J, Bommelaer G, Bourreille A, Fumery M, Roblin X, Reinisch W,…
Lire la suite
2016
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab
Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F,…
Lire la suite
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…
Lire la suite
Costs of Crohn’s Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.
Boschetti G, Nancey S, Daniel F, Pariente B, Lerebours E, Duclos B, Bourreille A, Cadiot G, Fumery M, Moreau J, Marteau P, Bouhnik Y, Louis E, Flourie B (Inflamm Bowel Dis. 2016 Dec;22(12) –…
Lire la suite
Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.
Abitbol Y, Laharie D, Cosnes J, Allez M, Nancey S, Amiot A, Aubourg A, Fumery M, Altwegg R, Michetti P, Chanteloup E, Seksik P, Baudry C, Flamant M, Bouguen G, Stefanescu C, Bourrier A,…
Lire la suite
Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn’s Disease.
Marteau P, Laharie D, Colombel JF, Martin L, Coevoet H, Allez M, Cadiot G, Bourreille A, Carbonnel F, Bouhnik Y, Coffin B, Duclos B, Dupas JL, Moreau J, Louis E, Mary JY (J Crohns…
Lire la suite
Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.
Poullenot F, Seksik P, Beaugerie L, Amiot A, Nachury M, Abitbol V, Stefanescu C, Reenaers C, Fumery M, Pelletier AL, Nancey S, Peyrin-Biroulet L, Bourreille A, Hébuterne X, Brixi H, Savoye G, Lourenço N,…
Lire la suite
Structural robustness of the gut mucosal microbiota is associated with Crohn’s disease remission after surgery
Mondot S, Lepage P, Seksik P, Allez M, Tréton X, Bouhnik Y, Colombel JF, Leclerc M, Pochart P, Doré J, Marteau P (Gut. 2016 Jun;65(6):954-62. – PMID: 26628508) https://pubmed.ncbi.nlm.nih.gov/26628508/
Lire la suite
Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial.
Senéjoux A, Siproudhis L, Abramowitz L, Munoz-Bongrand N, Desseaux K, Bouguen G, Bourreille A, Dewit O, Stefanescu C, Vernier G, Louis E, Grimaud JC, Godart B, Savoye G, Hebuterne X, Bauer P, Nachury M,…
Lire la suite
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti-Tumor Necrosis Factor Agents.
Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Grimaud JC, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V,…
Lire la suite